Regulatory T cells in the periphery
- PMID: 16903912
- DOI: 10.1111/j.0105-2896.2006.00414.x
Regulatory T cells in the periphery
Abstract
Recognition of a systemic antigen by CD4+ T cells in a lymphopenic host leads to the sequential generation of pathogenic effector cells and protective CD25+ forkhead box protein (Foxp3+) regulatory T cells (Tregs) in the periphery. Such an experimental model is potentially valuable for defining the stimuli that determine the balance of effector and regulatory T cells. Our studies have shown that interleukin-2 (IL-2) enhances the development of effector cells and is essential for the peripheral generation of regulatory cells. Other models of peripheral Treg generation suggest that the concentration of antigen, the nature of the antigen-presenting cells, and cytokines such as transforming growth factor-beta and IL-10 may all influence the peripheral generation of Tregs.
Similar articles
-
Recent thymic origin, differentiation, and turnover of regulatory T cells.J Leukoc Biol. 2008 Nov;84(5):1287-97. doi: 10.1189/jlb.0308201. Epub 2008 Aug 5. J Leukoc Biol. 2008. PMID: 18682578
-
The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.Transpl Immunol. 2009 Mar;20(4):253-60. doi: 10.1016/j.trim.2008.12.001. Epub 2009 Jan 13. Transpl Immunol. 2009. PMID: 19146957
-
Transforming growth factor beta-producing Foxp3(+)CD8(+)CD25(+) T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions.Exp Eye Res. 2007 Nov;85(5):626-36. doi: 10.1016/j.exer.2007.07.015. Epub 2007 Jul 25. Exp Eye Res. 2007. PMID: 17720157
-
The roles for cytokines in the generation and maintenance of regulatory T cells.Immunol Rev. 2006 Aug;212:114-30. doi: 10.1111/j.0105-2896.2006.00407.x. Immunol Rev. 2006. PMID: 16903910 Review.
-
Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer.Immunol Rev. 2006 Aug;212:163-9. doi: 10.1111/j.0105-2896.2006.00411.x. Immunol Rev. 2006. PMID: 16903913 Review.
Cited by
-
Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers.Oncotarget. 2018 Feb 16;9(19):14909-14921. doi: 10.18632/oncotarget.24504. eCollection 2018 Mar 13. Oncotarget. 2018. PMID: 29599915 Free PMC article.
-
Diverse continuum of CD4+ T-cell states is determined by hierarchical additive integration of cytokine signals.Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6447-E6456. doi: 10.1073/pnas.1615590114. Epub 2017 Jul 17. Proc Natl Acad Sci U S A. 2017. PMID: 28716917 Free PMC article.
-
RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.J Immunol. 2021 Oct 15;207(8):2027-2038. doi: 10.4049/jimmunol.2100175. Epub 2021 Sep 13. J Immunol. 2021. PMID: 34518282 Free PMC article.
-
CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.Immunity. 2008 Nov 14;29(5):771-81. doi: 10.1016/j.immuni.2008.08.018. Immunity. 2008. PMID: 18993084 Free PMC article.
-
Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells.Immunity. 2009 Jan 16;30(1):155-67. doi: 10.1016/j.immuni.2008.12.009. Immunity. 2009. PMID: 19144320 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials